Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib

Eur J Haematol. 2005 Jan;74(1):89-90. doi: 10.1111/j.1600-0609.2004.00347.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Pericardial Effusion / chemically induced*
  • Pericardial Effusion / etiology
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Pleural Effusion / chemically induced*
  • Pleural Effusion / etiology
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate